82 related articles for article (PubMed ID: 21556529)
1. Rflp analysis of the L-myc oncogene in head and neck-cancer - relationship study with susceptibility and disease progression.
Millon R; Muller D; Velten M; Doffoel S; Eber M; Engelmann A; Bronner G; Flesch H; Methlin G; Abecassis J
Int J Oncol; 1995 Jan; 6(1):237-42. PubMed ID: 21556529
[TBL] [Abstract][Full Text] [Related]
2. Is there any correlation between restriction fragment length polymorphism of the L-MYC gene and metastasis of human nonsmall cell lung cancer?
Yaylim I; Isbir T; Oztürk O; Turna A; Işitmangil T; Zonüzi F; Camlica H
Cancer Genet Cytogenet; 2002 Apr; 134(2):118-22. PubMed ID: 12034523
[TBL] [Abstract][Full Text] [Related]
3. EcoRI polymorphism of the L-myc gene in gastric cancer patients.
Dlugosz A; Adler G; Ciechanowicz A; Jaroszewicz-Heigelmann H; Starzynska T
Eur J Gastroenterol Hepatol; 2002 Nov; 14(11):1231-5. PubMed ID: 12439118
[TBL] [Abstract][Full Text] [Related]
4. L-myc restriction fragment length polymorphism in Japanese patients with esophageal cancer.
Shibuta K; Inoue H; Sato K; Matsuyama A; Ueo H; Tanaka Y; Mafune K; Barnard GF; Mori M
Jpn J Cancer Res; 2000 Feb; 91(2):199-203. PubMed ID: 10761707
[TBL] [Abstract][Full Text] [Related]
5. Restriction fragment length polymorphism of the L-myc oncogene in non-Hodgkin's lymphoma patients from India.
Fernandez T; Saranath D; Advani SH; Deo MG; Soman CS
Cancer Lett; 1998 Mar; 125(1-2):165-9. PubMed ID: 9566711
[TBL] [Abstract][Full Text] [Related]
6. Association between restriction fragment length polymorphism of the L-myc gene and susceptibility to gastric cancer.
Shibuta K; Mori M; Haraguchi M; Yoshikawa K; Ueo H; Akiyoshi T
Br J Surg; 1998 May; 85(5):681-4. PubMed ID: 9635822
[TBL] [Abstract][Full Text] [Related]
7. Correlation of L-myc RFLP with metastasis, prognosis and multiple cancer in lung-cancer patients.
Kawashima K; Nomura S; Hirai H; Fukushi S; Karube T; Takeuchi K; Naruke T; Nishimura S
Int J Cancer; 1992 Feb; 50(4):557-61. PubMed ID: 1347036
[TBL] [Abstract][Full Text] [Related]
8. Restriction fragment length polymorphism of the L-myc gene in oral cancer patients.
Saranath D; Panchal RG; Nair R; Mehta AR; Sanghavi V; Deo MG
Br J Cancer; 1990 Apr; 61(4):530-3. PubMed ID: 1970484
[TBL] [Abstract][Full Text] [Related]
9. Increased frequency of the S-allele of the L-myc oncogene in breast cancer.
Isbir T; Yaylim I; Arîkan S; Küçücük S; Camlíca H
Mol Med; 2002 Sep; 8(9):521-4. PubMed ID: 12456990
[TBL] [Abstract][Full Text] [Related]
10. Association of the SS genotype of the L-myc gene and loss of 18q sequences with a worse clinical prognosis in colorectal cancers.
Young J; Buttenshaw R; Butterworth L; Ward M; Searle J; Leggett B; Chenevix-Trench G
Oncogene; 1994 Apr; 9(4):1053-6. PubMed ID: 7907781
[TBL] [Abstract][Full Text] [Related]
11. Restriction fragment length polymorphism of the L-myc gene and susceptibility to metastasis in genitourinary cancers.
Kakehi Y; Taki Y; Yoshida O
Urol Int; 1991; 47 Suppl 1():86-9. PubMed ID: 1683040
[TBL] [Abstract][Full Text] [Related]
12. L-myc restriction fragment length polymorphism and histological pattern of invasion in lung adenocarcinoma.
Suzuki H; Yamashiro K
Oncol Rep; 2002; 9(2):345-7. PubMed ID: 11836605
[TBL] [Abstract][Full Text] [Related]
13. Different susceptibility of each L-myc genotype to esophageal cancer risk factors.
Kumimoto H; Hamajima N; Nishizawa K; Nishimoto Y; Matsuo K; Harada H; Shinoda M; Hatooka S; Ishizaki K
Jpn J Cancer Res; 2001 Jul; 92(7):735-9. PubMed ID: 11473723
[TBL] [Abstract][Full Text] [Related]
14. L-myc polymorphism in head and neck nonmelanoma skin and lower lip cancers.
Gözü A; Ergen A; Dayicioglu D; Yaylim I; Ozsoy Z; Isbir T
Arch Otolaryngol Head Neck Surg; 2008 Jul; 134(7):725-8. PubMed ID: 18645122
[TBL] [Abstract][Full Text] [Related]
15. Restriction fragment length polymorphism of the L-myc gene and susceptibility to metastasis in renal cancer patients.
Kakehi Y; Yoshida O
Int J Cancer; 1989 Mar; 43(3):391-4. PubMed ID: 2564378
[TBL] [Abstract][Full Text] [Related]
16. L-myc gene polymorphism and risk of thyroid cancer.
Yaylim-Eraltan I; Bozkurt N; Ergen A; Zeybek U; Ozturk O; Arikan S; Erbil Y; Uslu I; Camlica H; Isbir T
Exp Oncol; 2008 Jun; 30(2):117-20. PubMed ID: 18566574
[TBL] [Abstract][Full Text] [Related]
17. Studies of the L-myc DNA polymorphism and relation to metastasis in Norwegian lung cancer patients.
Tefre T; Børresen AL; Aamdal S; Brøgger A
Br J Cancer; 1990 Jun; 61(6):809-12. PubMed ID: 1973618
[TBL] [Abstract][Full Text] [Related]
18. Role of L-MYC polymorphism in oral squamous cell carcinoma in Turkey.
Bektas-Kayhan K; Unür M; Yaylim-Eraltan I; Ergen A; Hafiz G; Karadeniz A; Isbir T
Anticancer Res; 2009 Jul; 29(7):2519-24. PubMed ID: 19596922
[TBL] [Abstract][Full Text] [Related]
19. Restriction fragment length polymorphism analysis of the L-myc gene locus in a case-control study of lung cancer.
Tamai S; Sugimura H; Caporaso NE; Resau JH; Trump BF; Weston A; Harris CC
Int J Cancer; 1990 Sep; 46(3):411-5. PubMed ID: 1975565
[TBL] [Abstract][Full Text] [Related]
20. Meta-analysis suggests association of L-myc EcoRI polymorphism with cancer prognosis.
Spinola M; Pedotti P; Dragani TA; Taioli E
Clin Cancer Res; 2004 Jul; 10(14):4769-75. PubMed ID: 15269151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]